Pharmacists in Indianapolis, Indiana
1388 Pharmacists found in Indianapolis
Jennifer Longenecker
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
6110 E 86th St, Indianapolis, IN 46250
317-558-1452
Dr. Jennifer Lynn Tutino, PHARMD
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
1002 W 10th St, Indianapolis, IN 46202
317-630-6015
Jennifer Helen Tobison, PHARMD
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
2001 W 86th St, Indianapolis, IN 46260
317-338-2905
Dr. Jennifer Elizabeth Bell, PHARMD, BCOP
Pharmacist - Oncology
9002 N Meridian St Ste 214, Indianapolis, IN 46260
317-735-7530 317-735-7541
Jennifer Macke Johnson, PHARMD
Pharmacist
9002 N Meridian St, Suite 213, Indianapolis, IN 46260
317-587-7400 317-587-7410
Dr. Jennifer Lynn Focht, PHARMD
Pharmacist
2550 Lake Circle Dr, Indianapolis, IN 46268
317-579-8136 317-579-8424
Jennifer Watson, RPH
Pharmacist
5325 E Southport Rd, Indianapolis, IN 46237
317-859-2210 317-859-2265
Mrs. Jeri Lynn Taylor, RPH
Pharmacist
6191 N Keystone Ave, Indianapolis, IN 46220
317-257-6746 317-257-6847
Mr. Jerrald Scott Pruner, RPH
Pharmacist - Pharmacotherapy
1481 W 10th St, Indianapolis, IN 46202
317-554-0000
Dr. Jerusah Kwamboka Okwoyo, PHARMD
Pharmacist
3805 S Keystone Ave, Indianapolis, IN 46227
317-786-3485
Mrs. Jeseca Martel Killeen, R.PH.
Pharmacist
1300 E 86th St, T-1848 Ste. 35, Indianapolis, IN 46240
317-810-0045
Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.